Extrapolating from those in vitro data would suggest that AML tolerance to CXCR4 inhibition through persistent surface localization of receptor occurs within a crucial time-window preceding the completion of the initial week-long induction chemotherapy. Here, CXCR4 is linked to acute myeloid leukemia.